Centerline Biomedical

Centerline Biomedical

Pre-clinical
Cleveland, United StatesFounded 2014centerlinebiomedical.com

Centerline Biomedical is a private medical device company focused on revolutionizing endovascular navigation. Its flagship product, the IOPS® system, is a 510(k) cleared, portable platform that provides real-time, 3D color image guidance, positioning itself as an alternative to traditional 2D X-ray fluoroscopy. The company's mission is to make healthcare safer and more accessible by mitigating the risks of radiation exposure and improving procedural outcomes for complex vascular surgeries. Its leadership team comprises seasoned executives with decades of experience in cardiovascular device innovation and commercialization.

Founded
2014
Focus
Medical DevicesCardiovascular

AI Company Overview

Centerline Biomedical is a private medical device company focused on revolutionizing endovascular navigation. Its flagship product, the IOPS® system, is a 510(k) cleared, portable platform that provides real-time, 3D color image guidance, positioning itself as an alternative to traditional 2D X-ray fluoroscopy. The company's mission is to make healthcare safer and more accessible by mitigating the risks of radiation exposure and improving procedural outcomes for complex vascular surgeries. Its leadership team comprises seasoned executives with decades of experience in cardiovascular device innovation and commercialization.

Technology Platform

The Intra-Operative Positioning System (IOPS®), a 3D electromagnetic GPS-like surgical navigation platform that provides real-time visualization of catheters and guidewires to reduce reliance on X-ray fluoroscopy and contrast dye during endovascular procedures.

Funding History

2

Total raised: $35M

Series B$20MUndisclosedJun 15, 2021
Series A$15MUndisclosedJun 15, 2018

Opportunities

Significant growth opportunity lies in displacing the standard of care (fluoroscopy) in over 4 million annual endovascular procedures.
Expansion into adjacent markets like interventional cardiology and neurology, development of new disposable instruments, and potential strategic partnerships or acquisition by a larger medtech company are key avenues for growth.

Risk Factors

Key risks include slow adoption due to entrenched clinical workflows, competition from large imaging incumbents improving their own dose-reduction technologies, challenges in securing adequate reimbursement, and the execution risk of scaling a commercial-stage medical device company.

Competitive Landscape

Competes directly with the entrenched standard of X-ray fluoroscopy systems (Siemens, GE, Philips) and indirectly with other advanced surgical navigation platforms. Centerline differentiates by making radiation and contrast reduction its core, marketing-focused mission, offering portability, and providing intuitive 3D color guidance.

Company Info

TypeMedical Devices
Founded2014
LocationCleveland, United States
StagePre-clinical
RevenueEarly Revenue

Therapeutic Areas

Vascular SurgeryInterventional CardiologyInterventional Radiology
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile